Medical Supply Chain Resiliency Act

Bill 119 s 998, also known as the "Medical Goods Trade Agreement Act," is a proposed legislation that aims to give the President the authority to negotiate trade agreements with other countries to eliminate tariffs and other import restrictions on medical goods. The main goal of this bill is to enhance national security and public health in the United States by ensuring access to essential medical supplies.

The bill emphasizes the importance of having a reliable and efficient supply chain for medical goods, especially in times of crisis such as pandemics or natural disasters. By reducing barriers to trade, the United States can ensure a steady flow of medical supplies and equipment, ultimately benefiting the health and well-being of its citizens.

In addition to promoting the reciprocal elimination of duties on medical goods, the bill also includes provisions for monitoring and enforcing these trade agreements. This is to ensure that the United States is able to maintain a stable and secure supply of medical goods, even in the face of global challenges. Overall, Bill 119 s 998 seeks to strengthen the United States' ability to respond to public health emergencies and safeguard the nation's security by facilitating trade agreements that promote the free flow of essential medical supplies.